AllBright


锦天城律师事务所香港分所近日获得香港律师会批准本地化,未来将以“锦天城(香港)律师事务所有限法律责任合伙 AllBright Law (Hong Kong) Offices LLP”的名字拥有香港本地律所执业资格,并继续与香港史蒂文生黄律师事务所联营。

据悉,锦天城早于2013年便与史蒂文生黄展开联营,是彼时锦天城国际化布局的第一步。2015年,两家机构还设立了锦天城史蒂文生黄(前海)联营律师事务所,成为第一批在前海成立的联营律师事务所。

根据香港律师会网站,锦天城在香港注册有八名外地律师,不过其常驻深圳的高级合伙人杜晓东律师主要负责相关业务。杜律师是资本市场专家,深耕于生物医药领域,他也主导了2021年康诺亚在香港的上市项目。

锦天城表示,获得本地牌照的锦天城香港将着重于招贤纳士,尤其期待具备香港和/或外国律师执业资格的执业者加入,为内地、香港两地客户提供资本市场、公司合规、跨境并购、银行金融、房地产、雇佣移民、私募基金、竞争法、知识产权、争议解决、高端私人客户家事、家族办公室等全方位法律服务。

锦天城香港本地化也将进一步加强其在粤港澳大湾区的布局,目前锦天城在大湾区同时拥有深圳、广州办公室。

AllBright becomes latest PRC firm to obtain local license in Hong Kong

The Hong Kong office of Shanghai-headquartered AllBright Law Offices has recently received approval from the Law Society of Hong Kong to localize its operations. It will practice under the name AllBright Law (Hong Kong) Offices LLP in the future and continue its association with local Hong Kong firm Stevenson, Wong & Co.

AllBright entered into an association with Stevenson Wong in 2013, marking the first step of its internationalization strategy. In 2015, the two firms also established a joint venture law firm in Shenzhen’s Qianhai zone, becoming one of the first to do so.

According to the website of the Law Society, AllBright has eight registered foreign lawyers in Hong Kong, with its senior partner, Du Xiaodong, who is based in Shenzhen most of the time, primarily responsible for relevant business. Du specializes in capital markets and has accumulated experience in the biotech sector. He also led the listing project of Keymed Biosciences in Hong Kong back in 2021.

AllBright stated that its new Hong Kong office will focus on attracting talents, especially practitioners with qualifications as Hong Kong and/or foreign lawyers. It aims to provide comprehensive legal services in areas such as capital markets, corporate compliance, cross-border mergers and acquisitions, banking and finance, real estate, private equity, intellectual property, dispute resolution, family offices, and more, for clients in mainland China and Hong Kong.

The localization of AllBright in Hong Kong will also further strengthen its presence in the Greater Bay Area, where the firm currently also has offices in Shenzhen and Guangzhou.

TO CONTACT EDITORIAL TEAM, PLEASE EMAIL ALBEDITOR@THOMSONREUTERS.COM

Related Articles

锐敏、锦天城等助力阿斯利康以12亿美元成功收购亘喜生物(ZH/EN)

近日,中国生物科技公司亘喜生物宣布正式完成与阿斯利康集团的合并协议,总交易价值高达12亿美元。

通力、锦天城助力A股今年迄今最大IPO项目(ZH/EN)

8月7日,总部位于上海的华虹半导体有限公司在上交所科创板成功上市,募资212.03亿元,成为2023年迄今募集资金规模最大的A股IPO项目,也是仅次于中芯国际、百济神州的科创板史上第三大IPO项目。

锦天城落子昆明,强化西南布局(ZH/EN)

by Charlie Wu 吴卓言 |

总部位于上海的锦天城律师事务所近日正式开设昆明办公室,成为该所在国内的第25家分所。